Evaluation of the Directly Observed Treatment’s Acceptance by Tuberculosis Patients in the Republic of Macedonia
DOI:
https://doi.org/10.3889/oamjms.2018.204Keywords:
directly observed therapy, home visits, treatment outcomeAbstract
BACKGROUND: Directly observed therapy (DOT) is a specific strategy endorsed by the World Health Organization in 1994 to improve adherence by requiring health workers, community volunteers or family members to observe and record tuberculosis (TB) patients for taking each dose. The implementation of DOT strategy in the National Tuberculosis Programme (NTP) in Macedonia was introduced in 2006 and was realised by 6 nurses engaged through the Project of Global Fund against HIV/AID and TB.
AIM: This study aimed to evaluate how these visits conducted by the DOT nurses engaged through the GF were accepted by TB patients and to evaluate the impact on the treatment outcomes.
PATIENTS AND METHODS: In this prospective study 105 TB patients who started treatment in 2016 and who were supposed to be visited by DOT nurses at their homes were included. All of these patients filled out a questionnaire compiled of 6 questions related to their opinion about the efficacy and usefulness of the visits managed by the nurses when they would come for check-ups at the Institute for Lung Diseases and Tuberculosis. The assessment of the efficacy of the work of DOT nurses was performed by analysis of the answers received by TB patients. The data were analysed with the method of description and was statistically prepared in the program SPSS for Windows, 17.0.
RESULTS: The results from the analyses showed that the number of visited patients were not satisfied, because 29.52%% were never visited by a DOT nurse at their homes. A lot of patients (61.91%) were not willing to take medicines under the observed control by nurses. Those TB patients who were visited by DOT nurses thought that this type of visit is useful for them: they were satisfied by the attitude of the nurses during the visits, and they received enough explanations regarding TB.
CONCLUSION: We can conclude that the DOT visits to TB patients are useful, contribute patients to complete the therapeutic regime without interruption, take care for every individual patient effectively, and protect the rest of society by preventing the development and spread of TB, including drug-resistant strains.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
World Health Organization 2007. Global tuberculosis control: surveillance, planning, financing. WHO report. Geneva, Switzerland: World Health Organization (WHO/HTM/TB/2007.376), 2007.
Bayer R, Wilkinson D. Directly observed therapy for tuberculosis control: history of an idea. Lancet. 1995; 345:1545–48. https://doi.org/10.1016/S0140-6736(95)91090-5
Treatment of tuberculosis - guidelines for national programmes, 3rd ed. Geneva, World Health Organization (WHO/CDS/TB/2003.313), 2003.
Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. J Am Med Assoc. 2005; 293:2767–75. https://doi.org/10.1001/jama.293.22.2767 PMid:15941807
Baltussen R, Floyd K, Dye C H. Cost effectiveness analysis ofstrategies for tuberculosis control in developing countries. BMJ. 2005; 331:1364. https://doi.org/10.1136/bmj.38645.660093.68 PMid:16282379 PMCid:PMC1309642
Volmink J, Garner P Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2006; 2:CD003343. https://doi.org/10.1002/14651858.CD003343.pub2
Rusen ID, Ait-Khaled N, Alarcon E. Cochrane systematic review of directly observed therapy for treating tuberculosis: good analysis of the wrong outcome. Int J Tuberc Lung Dis. 2007; 11:120–121. PMid:17263279
Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2015; 5:1–56. https://doi.org/10.1002/14651858.CD003343.pub4
Volmink J, Matchaba P, Garner P. Directly observed therapy and treatment adherence. Lancet. 2000; 355:1345–1350. https://doi.org/10.1016/S0140-6736(00)02124-3
Davies P. The role of DOTS in tuberculosis treatment and control. Am J Respir Med. 2003; 2: 203–209. https://doi.org/10.1007/BF03256649 PMid:14720002
Malotte CK, Hollingshead JR, Larro M. Incentives vs outreach workers for latent tuberculosis treatment in drug users. Am J Prev Med. 2001; 20: 103–107. https://doi.org/10.1016/S0749-3797(00)00283-X
Sumartojo E. When tuberculosis treatment fails. A social behavioural account of patients adherence. Am Rev Respir Dis. 1993; 147:1311–1320. https://doi.org/10.1164/ajrccm/147.5.1311 PMid:8484650
Lienhardt CH, Odgen JA. Tuberculosis control in resource poor countries: have we reached the limits of the universal paradigm? Tropical Med Intern Health. 2004; 9: 833–841. https://doi.org/10.1111/j.1365-3156.2004.01273.x PMid:15228495
Cremers AL, de Laat MM, Kapata N, Gerrets R, Klipstein-Grobusch K, Grobusch MP. Assessing the consequences of stigma for tuberculosis patients in urban Zambia. PLoS One. 2015;10: e0119861. https://doi.org/10.1371/journal.pone.0119861 PMid:25806955 PMCid:PMC4373828
World Health Organization. Global Tuberculosis Report 2015, 2015.
Dye C, Floyd K, Uplekar M. Global tuberculosis control: surveillance, planning, financing; WHO report 2008, 2008.
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
